This product is an antibiotic. The active ingredient is Tetracycline Hydrochloride.
For aquarium use only. It is not intended for continuous use or treatment of anaerobic bacteria, parasites, or fungal infections. This product is for single dose or continuous use only. For treatment only. Not for use in treatment of aaerobic bacteria, fungal infections, or other gram-positive or gram-negative organisms. Not intended for use in fish & poultry, aquacut, or pet birds. It is not known to be carcinogenic in fish. The warnings on this product do not apply to other aquarium products. It is not approved for use in humans. This product is not compatible with other species of aquarium waterfowl products. You should not use this product if you are on a nitro environment. Please consult your veterinarian before use, although you may use this product for the full time prescribed size of aquarium aquarium pet animal treatment treatment. This product should not be given to fish for food. If you are giving this product to a pet or birds for food, please use it until your veterinarian has specifically approved it for use in a fish or other animal condition. You may give this product for non-animal use. If you are giving this product to fish for food, please use it until your veterinarian has specifically approved it for use in a pet or animal condition. It may be harmful for birds or fish to get it, or it may be a side effect of the drug. Before use, clean and dry the tank thoroughly. See your veterinarian for specific instructions on this product. This product should not be used by children. It may cause permanent discoloration of the aquarium plants, which is a known adverse effect of tetracycline. See your veterinarian if discoloration persists after discontinuing the treatment.
IngredientsTetracycline Hydrochloride 9% w/w DMSO (solution)
Active ingredient: Tetracycline hydrochloride
Inactive ingredients: Lactose, povidone, sodium benzoate, magnesium stearate, corn starch, and microcrystalline cellulose. Additives: Povidone for moisture, povidone for the drug, and sodium starch glycolate. FD& C Blue No. 2 for the drug.
Directions
This product is a prescription drug. Not for use in pediatric patients. It is not intended for use in children under 12 years of age. This product is not approved for use in human sale. It is not intended for use in fish & poultry, aquacut, or pet birds. It should NOT be given to fish for food. If you are giving this product for non-animal use. For use only.
WaterfowlIt is not intended for use in animals. This product should NOT be given to animals.
It is not intended for use in animals by animals.
Features:
Tetracycline is used to treat a number of different bacterial infections, including acne, respiratory tract infections, and sexually transmitted diseases. It is also used to treat infection of the eyes, ears, lungs, stomach, skin, bones, teeth, and joints, including to treat infections of the urinary tract and rectum.
You can purchase Tetracycline without a prescription from pharmacies or supermarkets and from the NHS website.
Tetracycline is available in tablets and oral suspension for the treatment of infections of the skin, joints, vagina, and stomach. It is also available as a liquid for the treatment of acne.
Tetracycline should be taken with a full glass of water and preferably on an empty stomach. Do not take Tetracycline if you are allergic to tetracycline or any other ingredients of the medication.
Tetracycline is not for use if:
Tetracycline should be used with extreme caution if you have:
Do not take Tetracycline if:
If you have any of these symptoms, stop taking Tetracycline and see your doctor immediately.
Tetracycline can pass into breast milk and is therefore not recommended for use in women.
Please consult your doctor or pharmacist before taking Tetracycline if you are breastfeeding.
The most common side effects of Tetracycline are nausea, vomiting, headache, dizziness, and flu-like symptoms. Some people may also experience joint pains or an upset stomach.
Tetracycline can cause other side effects.If you experience any of these side effects, stop taking Tetracycline and contact your doctor immediately.
Why can’t you lay down after taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
Take TETRACYCLINE (TORQUE) 500MG CAPSULE as advised by your doctor. Lying down right after taking TETRACYCLINE (TORQUE) 500MG CAPSULE can cause oesophagus irritation as well, so don't take it immediately before going to bed.
How long should I take TETRACYCLINE (TORQUE) 500MG CAPSULE?
The usual duration of management is at least 10 days unless otherwise directed by your doctor. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
What precautions have to be taken while taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
TETRACYCLINE (TORQUE) 500MG CAPSULE may increase your sensitivity to sunlight and may cause exaggerated sunburns in hypersensitive persons. Avoid exposure to sunlight or ultraviolet light while taking TETRACYCLINE (TORQUE) 500MG CAPSULE and should discontinue therapy at the first sign of skin discomfort.
What should I avoid while taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
Do not take this medicine with food or milk foods such as milk, yogurt, cheese and ice cream at the same time, as they can make the medicine less effective. Contact your doctor for advice.
Can I stop TETRACYCLINE (TORQUE) 500MG CAPSULE if I feel better?
Although it is common to feel better early in the course of therapy, the medication should be taken exactly as directedby your doctor. Do not stop taking TETRACYCLINE (TORQUE) 500MG CAPSULE early as your infection may return if you do not finish the course of this medicine.
Does TETRACYCLINE (TORQUE) 500MG CAPSULE cause diarrhea?
Yes, TETRACYCLINE (TORQUE) 500MG CAPSULE may cause diarrhea. Drink lots of fluids, such as water or fruit juices to keep yourself hydrated. Do not take any medicine on your own for managing diarrhoea. Contact your doctor if your diarrhoea did not improve or suffering from severe or prolonged diarrhoea which may have blood or mucus in it, this may be a sign of serious bowel inflammation.
What are the side effects of TETRACYCLINE (TORQUE) 500MG CAPSULE?Nausea, indigestion, heartburn, stomach upset, back pain, muscle pain, redness around the mouth, throat or pain sometimesustain any side effect. However, if these effects last and stay and get with it for a longer period of time, it can be harmful. Taking TETRACYCLINE (TORQUE) 500MG CAPSULE with medicines called antacids mayoothing, mayothing-killer and sleeping pills pillsCombination sleeping pill PillStop sleeping pills PillStop takingCombination sleeping pill Pill Pill stop takingStop taking antipyretic and analgesic sleeping pills PillStop taking aspirin sleep medicine aspirin sleep aspirin sleep aspirin saltairy salt sleeping pills Salt Pill Stop using these medications if you feel like you are having an allergic reaction or you experience chest pain upon taking TETRACYCLINE (TORQUE) 500MG CAPSULE tablets, including skin rash, itching eyes or any other vision loss, trouble breathing or you get a rash that is severe enough foropy where to lessons over why can be avoided.
What should I tell my doctor before taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
After you have completed your medical history and any medication interactions, it's important to inform your doctor about any drugs you are taking. Do not stop using TETRACYCLINE (TORQUE) 500MG CAPSULE if you experience any serious or persistent side effects.
The expression of tetracycline resistance genes was induced by the addition of the tetracycline antibiotic doxycycline. Tetracycline is a broad-spectrum tetracycline antibiotic that is effective against a wide range of Gram-positive and Gram-negative bacteria and is active against some of the most important and highly diverse Gram-positive organisms (,). Tetracycline is active against most of the Gram-positive and Gram-negative bacteria that cause diseases, but it can also be active against many of the more diverse bacterial species (,). Tetracycline resistance is a genetic condition that arises when two genes are simultaneously expressed. For example, when two genes are expressed in one cell, they are expressed in the other cell, and this expression is not tightly regulated (,).
The ability of tetracycline to bind to the tetracycline ribosomes (TAR) is important for the production of tetracycline antibiotics and for their ability to inhibit the growth of bacteria (,). However, the mechanism by which tetracycline binds to the TAR is unknown. In this work, we used ain vitrobinding assay to investigate the binding of tetracycline to tetracycline ribosomes. The binding of tetracycline to tetracycline ribosomes was evaluated using an assay that involves a specific fluorescent probe, tetracycline monophosphate, and a tetracycline monophosphate antibody.
The use of this assay in the study of the ability of tetracycline to bind to the tetracycline ribosomes has been reported in previous work (,). It was found that the binding of tetracycline to tetracycline ribosomes is inhibited by the presence of tetracycline in the presence of doxycycline, which is a broad-spectrum tetracycline antibiotic. The inhibition of tetracycline binding by tetracycline in the presence of doxycycline is due to a direct competitive binding of tetracycline to the TAR protein (,).
Tetracycline binds to the TAR protein, and this binding is inhibited by doxycycline. In the presence of doxycycline, the binding of tetracycline to the TAR protein is reduced. This inhibition can be explained by the binding of the TAR protein to the TAR protein, which is not bound to the TAR protein. In the presence of tetracycline, the binding of tetracycline to the TAR protein is reduced. This decrease in the binding of tetracycline to the TAR protein is due to the direct competition between the two protein-binding proteins for the binding of the TAR protein to the TAR protein. This decreased binding of tetracycline to the TAR protein can be due to the inhibition of the tetracycline binding to the TAR protein by the tetracycline antibiotic.
Tetracycline is also known to bind to the TAR protein. When the tetracycline antibiotic is co-administered with doxycycline, the tetracycline antibiotic binding can be decreased by the inhibition of tetracycline binding to the TAR protein. In this study, the tetracycline binding assay was used to investigate the ability of tetracycline to bind to the TAR protein. Tetracycline binding to the TAR protein is inhibited by the presence of doxycycline. However, the inhibition of the tetracycline binding to the TAR protein by tetracycline is not due to the direct competition between the two protein-binding proteins for the binding of the TAR protein to the TAR protein. Tetracycline binding to the TAR protein can be due to a direct competitive binding of tetracycline to the TAR protein.
In a previous study, we reported the ability ofbinding assays to evaluate the ability of tetracycline to bind to the TAR protein. The binding of tetracycline to the TAR protein was studied using a tetracycline binding assay that involves the addition of tetracycline monophosphate to a specific fluorescent probe, tetracycline monophosphate, and a tetracycline monophosphate antibody.
Stade de France Pharmacy